PDG25 COST-EFFECTIVENESS OF ONCE WEEKLY DULAGLUTIDE 1.5 MG VERSUS ONCE DAILY LIRAGLUTIDE 1.8 MG FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA

May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.704
https://www.valueinhealthjournal.com/article/S1098-3015(19)30896-4/fulltext
Section Title :
Section Order : 10308
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30896-4&doi=10.1016/j.jval.2019.04.704
HEOR Topics :
Tags :
Regions :